Ai:leen Health

About Ai:leen Health

Ai:leen Health is a medical technology start-up founded in 2022 in Salzburg with 2 to 10 employees. The company develops the AI platform Cancer4D, a 4D generative AI that predicts, on the basis of multimodal patient data, how a patient will respond to various cancer therapies. The software analyzes medical imaging data (currently breast and brain, with lung and prostate planned) and delivers non-invasive diagnoses with prognosis as an alternative to biopsy. Fields of application are oncology as well as neurological diseases such as Alzheimer's and multiple sclerosis; the network comprises around 300 healthcare providers as data feedback partners. The market launch with first pilot projects in the USA is planned for 2026, followed by expansion into Europe. Founder and CEO is Anna Tidstam, PhD, EMBA.

Site

Salzburg

Processes

AI-based cancer diagnosis and prognosis (Cancer4D GenAI), Virtual phase III trials for validation, Non-invasive alternative to biopsy, Regulatory innovation for 4D generative AI

Employees

2-10

Industries

Oncology, Neurology, Medical technology, Pharmaceuticals, Healthcare system, Neurology – Alzheimer's and multiple sclerosis

1. 01

   Data acquisition (multimodal patient data, imaging data)

2. 02

   AI training (deep learning, pattern recognition)

3. 03

   Diagnosis and prognosis modeling

4. 04

   Validation (virtual phase III trials)

5. 05

   Integration into clinical and regulatory processes

Locations

History

1. 2022

   aws Preseed funding Innovative Solutions in Salzburg

2. 2026

   Planned market launch with first pilot projects in the USA